miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text

Medicine, Oncology, Radiation Oncology +12

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

Joachim Silber, Daniel A. Lim, Claudia Petritsch et al. · BMC Medicine · 2008 · 948 citations · Full text

Medicine, Molecular Biology, Oncology +17

COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells

Mitsugu Fujita, Gary Kohanbash, Wendy Fellows-Mayle et al. · Cancer Research · 2011 · 379 citations · Full text

Medicine, Oncology, Pharmacology +17

MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma

Chunzhi Zhang, Junxia Zhang, Anling Zhang et al. · Molecular Cancer · 2010 · 319 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.

Tadahisa Shono, Philip J. Tofilon, J. M. Bruner et al. · PubMed · 2001 · 304 citations

Medicine, Oncology, Pathology +15